miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral...

Area of Science:

• Neuroscience
• Vascular Biology
• Molecular Biology

Background:

• Chronic Cerebral Hypoperfusion (CCH) is a significant risk factor for vascular dementia, yet effective treatments are lacking.
• The precise mechanisms underlying CCH-induced cognitive deficits remain poorly understood.
• Methyl cytidine-phosphate-guanosine (CpG) binding protein 2 (MeCP2), regulated by microRNA 132 (miR-132), plays a role in synaptic function and neuroplasticity.

Purpose of the Study:

• To investigate the expression of MeCP2 in the context of CCH.
• To explore the association between MeCP2 alterations and cognitive deficits following CCH.
• To elucidate the role of miR-132 in regulating MeCP2 expression in CCH models.

Main Methods:

• A rat model of permanent bilateral common carotid artery occlusion (2VO) was used to induce CCH.
• MeCP2 expression was analyzed using Western blotting, qRT-PCR, and immunofluorescence.
• Cognitive function and neuroplasticity were assessed via the Morris water maze and electrophysiology following lentivirus-mediated MeCP2 manipulation.

Main Results:

• CCH led to decreased MeCP2 expression in the hippocampus and cortex.
• Upregulated miR-132 in response to 2VO was negatively correlated with MeCP2 downregulation.
• Overexpression of MeCP2 ameliorated learning and memory impairments and enhanced neuroplasticity, restoring BDNF signaling pathways.

Conclusions:

• MiR-132 contributes to MeCP2 downregulation in CCH.
• MeCP2 downregulation is implicated in CCH-induced cognitive deficits via regulation of BDNF pathways.
• These findings offer insights into the molecular mechanisms of vascular dementia and potential therapeutic targets.